tiprankstipranks
Sangamo Therapeutics (SGMO)
NASDAQ:SGMO
US Market
SGMO
Sangamo Therapeutics
RESEARCH TOOLSreports
Want to see SGMO full AI Analyst Report?

Sangamo Therapeutics (SGMO) Income Statement

2,654 Followers

Sangamo Therapeutics Income Statement

Last quarter (Q4 2025), Sangamo Therapeutics's total revenue was $14.23M, an increase of 88.43% from the same quarter last year. In Q4, Sangamo Therapeutics's net income was $-37.42M. See Sangamo Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 39.55M$ 57.80M$ 176.23M$ 111.30M$ 110.70M
Gross Profit
$ 31.95M$ 57.80M$ 176.23M$ 99.19M$ 110.70M
Operating Expenses
$ 139.95M$ 161.77M$ 450.24M$ 300.47M$ 294.04M
Depreciation and Amortization
$ 7.60M$ 9.36M$ 22.19M$ 12.11M$ 17.64M
EBITDA
$ -100.40M$ -89.09M$ -96.80M$ -189.17M$ -165.70M
Operating Income
$ -108.00M$ -103.97M$ -274.00M$ -201.28M$ -183.34M
Other Income/Expenses
$ -15.50M$ 5.86M$ 11.10M$ 9.43M$ 5.35M
Pretax Income
$ -123.50M$ -98.11M$ -262.90M$ -191.85M$ -177.99M
Net Income
$ -122.93M$ -97.94M$ -257.83M$ -192.28M$ -178.29M
Per Share Metrics
Basic EPS
$ -0.44$ -0.49$ -1.48$ -1.25$ -1.23
Diluted EPS
$ -0.44$ -0.49$ -1.48$ -1.25$ -1.23
Weighted Average Shares Outstanding
 280.19M 201.70M 174.44M 154.34M 144.57M
Weighted Average Shares Outstanding (Diluted)
 280.19M 201.70M 174.44M 154.34M 144.57M
Currency in USD

Sangamo Therapeutics Earnings and Revenue History